The 147th Annual Meeting of the American Neurological Association (ANA) will explore new frontiers in neurology, including the impact of climate change on the human brain, whether lab-grown brain structures can shed new light on neurologic disease, and how to address disparities in neurologic diagnosis and care for diverse populations. Taking
Dr. Shelley Hershner discussed the importance of logging enough shut-eye and offered tips for the audience during the 2022 Shankweiler Scholars Lecture.
Having a long-term pet companion may delay memory loss and other kinds of cognitive decline, a new study has found. Pet ownership was especially beneficial for working verbal memory, such as memorization of word lists, according to the preliminary research.
Stroke patients who have damage to their brain stem are more likely to have sleep apnea than those with damage in other parts of their brain, Michigan researchers report.
Dairy intake may increase risk of Parkinson's disease in men, according to investigators. Men of European ancestry with a genetic marker predicting dairy consumption had significantly greater risk of Parkinson's disease than individuals without the marker, suggesting a causal relationship between dairy intake and Parkinson's disease.
Advances in sleep research in 2021 have brought about clinical developments for the next decade.
Sleep medicine education was evaluated in a recently published study that enrolled 21 health professions trainees in a 2-day boot camp. The study cohort included 14 sleep medicine fellows who were about to enter their fellowship, with investigators concluding that baseline knowledge of sleep medicine is higher than originally anticipated and
Neurology experts reviewed the latest evidence to offer new recommendations for management of painful neuropathy in diabetes patients.
New findings from JAMA Neurology reported that physical activity, regardless of intensity, is associated with reduced all-cause mortality among individuals with Parkinson's disease. Those who began to exercise after their diagnosis also had lower all-cause mortality than those who did not do physical activity.
A new analysis from the Institute for Clinical and Economic Review said the evidence available to date shows moderate effectiveness of two newer drugs for myasthenia gravis—eculizumab and efgartigimod—but found their price exceedingly high and their use not cost-effective.
Get ready to turn your clocks back one hour this Sunday (Nov. 7) for Daylight Saving Time .
This fall we gain an hour and in the spring we’ll turn clocks
The number of people experiencing numbness, pins and needles, and burning pain in their feet and toes seems to be on the rise, new research suggests, and some of these folks may be at increased risk for heart trouble.
Observational evidence points towards earlier initiation of therapy, but a definitive answer awaits several RCTs.
The likelihood that opioid treatment for common neurological conditions was initiated appeared to decrease with greater access to neurologists or other specialists who offered alternative pain treatment.
One of the main reasons why millions of people drink coffee every day is because of its energy-boosting properties. Having trouble getting out of bed in the
"We’ve had multi-millions of cases of COVID in this country. I mean let’s do the math, when 20 percent of those individuals – we’re talking about millions of individuals who have long COVID, those individuals are really impaired." Dr. Eva Feldman speaks to One Detroit's Bill Kubota on Detroit Public Television about Long COVID.
What sleep experts say will help you get re-acclimated to a pre-pandemic schedule
